Safety of fluoroless radiofrequency catheter ablation for atrial fibrillation in patients with pre-existing cardiac implantable electronic device: A single-center study. Posted on December 5th, 2023 by LEADconnection Post navigation Previous: Reappraisal of [18F]FDG-PET/CT for diagnosis and management of cardiac implantable electronic device infectionsNext: Scoping review of percutaneous mechanical aspiration for valvular and cardiac implantable electronic device infective endocarditis.
Reappraisal of [18F]FDG-PET/CT for diagnosis and management of cardiac implantable electronic device infections Posted on December 5th, 2023 by LEADconnection Post navigation Previous: Do barrier dressings reduce cardiac implantable device infection: Protocol for a randomized controlled trial (BARRIER-PROTECT).Next: Safety of fluoroless radiofrequency catheter ablation for atrial fibrillation in patients with pre-existing cardiac implantable electronic device: A single-center study.
Do barrier dressings reduce cardiac implantable device infection: Protocol for a randomized controlled trial (BARRIER-PROTECT). Posted on December 5th, 2023 by LEADconnection Post navigation Previous: Practical Considerations for Cardiac Electronic Devices Reimplantation Following Transvenous Lead Extraction Due to Related Endocarditis.Next: Reappraisal of [18F]FDG-PET/CT for diagnosis and management of cardiac implantable electronic device infections